Automated PET-only quantification of amyloid deposition with adaptive template and empirically pre-defined ROI

被引:33
作者
Akamatsu, G. [1 ]
Ikari, Y. [1 ]
Ohnishi, A. [1 ]
Nishida, H. [1 ]
Aita, K. [1 ]
Sasaki, M. [1 ,3 ]
Yamamoto, Y. [2 ]
Sasaki, M. [1 ,3 ]
Senda, M. [1 ]
机构
[1] Inst Biomed Res & Innovat, Div Mol Imaging, Chuo Ku, 2-2 Minatojima Minamimachi, Kobe, Hyogo 6500047, Japan
[2] Kobe Univ, Grad Sch Med, Dept Psychiat, Chuo Ku, 7-5-2 Kusunoki Cho, Kobe, Hyogo 6500017, Japan
[3] Kyushu Univ, Grad Sch Med Sci, Dept Hlth Sci, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan
关键词
PET; amyloid; quantification; ALZHEIMERS ASSOCIATION WORKGROUPS; PITTSBURGH COMPOUND-B; DIAGNOSTIC GUIDELINES; NATIONAL INSTITUTE; DISEASE; BRAIN; MRI; RECOMMENDATIONS; PERFORMANCE; TRIALS;
D O I
10.1088/0031-9155/61/15/5768
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Amyloid PET is useful for early and/or differential diagnosis of Alzheimer's disease (AD). Quantification of amyloid deposition using PET has been employed to improve diagnosis and to monitor AD therapy, particularly in research. Although MRI is often used for segmentation of gray matter and for spatial normalization into standard Montreal Neurological Institute (MNI) space where region-of-interest (ROI) template is defined, 3D MRI is not always available in clinical practice. The purpose of this study was to examine the feasibility of PET-only amyloid quantification with an adaptive template and a pre-defined standard ROI template that has been empirically generated from typical cases. A total of 68 subjects who underwent brain C-11-PiB PET were examined. The C-11-PiB images were non-linearly spatially normalized to the standard MNI T1 atlas using the same transformation parameters of MRI-based normalization. The automatic-anatomical-labeling-ROI (AAL-ROI) template was applied to the PET images. All voxel values were normalized by the mean value of cerebellar cortex to generate the SUVR-scaled images. Eleven typical positive images and eight typical negative images were normalized and averaged, respectively, and were used as the positive and negative template. Positive and negative masks which consist of voxels with SUVR >= 1.7 were extracted from both templates. Empirical PiB-prone ROI (EPP-ROI) was generated by subtracting the negative mask from the positive mask. The C-11-PiB image of each subject was non-rigidly normalized to the positive and negative template, respectively, and the one with higher cross-correlation was adopted. The EPP-ROI was then inversely transformed to individual PET images. We evaluated differences of SUVR between standard MRI-based method and PET-only method. We additionally evaluated whether the PET-only method would correctly categorize C-11-PiB scans as positive or negative. Significant correlation was observed between the SUVRs obtained with AAL-ROI and those with EPP-ROI when MRI-based normalization was used, the latter providing higher SUVR. When EPP-ROI was used, MRI-based method and PET-only method provided almost identical SUVR. All C-11-PiB scans were correctly categorized into positive and negative using a cutoff value of 1.7 as compared to visual interpretation. The C-11-PiB SUVR were 2.30 +/- 0.24 and 1.25 +/- 0.11 for the positive and negative images. PET-only amyloid quantification method with adaptive templates and EPP-ROI can provide accurate, robust and simple amyloid quantification without MRI.
引用
收藏
页码:5768 / 5780
页数:13
相关论文
共 26 条
  • [1] Optimization of image reconstruction conditions with phantoms for brain FDG and amyloid PET imaging
    Akamatsu, Go
    Ikari, Yasuhiko
    Nishio, Tomoyuki
    Nishida, Hiroyuki
    Ohnishi, Akihito
    Aita, Kazuki
    Sasaki, Masahiro
    Sasaki, Masayuki
    Senda, Michio
    [J]. ANNALS OF NUCLEAR MEDICINE, 2016, 30 (01) : 18 - 28
  • [2] PET Quantification of 18F-Florbetaben Binding to β-Amyloid Deposits in Human Brains
    Becker, Georg A.
    Ichise, Masanori
    Barthel, Henryk
    Luthardt, Julia
    Patt, Marianne
    Seese, Anita
    Schultze-Mosgau, Marcus
    Rohde, Beate
    Gertz, Hermann-Josef
    Reininger, Cornelia
    Sabri, Osama
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2013, 54 (05) : 723 - 731
  • [3] Physical Performance of the new hybrid PET/CT Discovery-690
    Bettinardi, V.
    Presotto, L.
    Rapisarda, E.
    Picchio, M.
    Gianolli, L.
    Gilardi, M. C.
    [J]. MEDICAL PHYSICS, 2011, 38 (10) : 5394 - 5411
  • [4] Comparison of MR-less PiB SUVR quantification methods
    Bourgeat, Pierrick
    Villemagne, Victor L.
    Dore, Vincent
    Brown, Belinda
    Macaulay, S. Lance
    Martins, Ralph
    Masters, Colin L.
    Ames, David
    Ellis, Kathryn
    Rowe, Christopher C.
    Salvado, Olivier
    Fripp, Jurgen
    [J]. NEUROBIOLOGY OF AGING, 2015, 36 : S159 - S166
  • [5] Phase 3 Trials of Solanezumab for Mild-to-Moderate Alzheimer's Disease
    Doody, Rachelle S.
    Thomas, Ronald G.
    Farlow, Martin
    Iwatsubo, Takeshi
    Vellas, Bruno
    Joffe, Steven
    Kieburtz, Karl
    Raman, Rema
    Sun, Xiaoying
    Aisen, Paul S.
    Siemers, Eric
    Liu-Seifert, Hong
    Mohs, Richard
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2014, 370 (04) : 311 - 321
  • [6] Comparison of MRI based and PET template based approaches in the quantitative analysis of amyloid imaging with PIB-PET
    Edison, P.
    Carter, S. F.
    Rinne, J. O.
    Gelosa, G.
    Herholz, K.
    Nordberg, A.
    Brooks, D. J.
    Hinz, R.
    [J]. NEUROIMAGE, 2013, 70 : 423 - 433
  • [7] Brain templates and atlases
    Evans, Alan C.
    Janke, Andrew L.
    Collins, D. Louis
    Baillet, Sylvain
    [J]. NEUROIMAGE, 2012, 62 (02) : 911 - 922
  • [8] Comparison between brain CT and MRI for voxel-based morphometry of Alzheimer's disease
    Imabayashi, Etsuko
    Matsuda, Hiroshi
    Tabira, Takeshi
    Arima, Kunimasa
    Araki, Nobuo
    Ishii, Kenji
    Yamashita, Fumio
    Iwatsubo, Takeshi
    [J]. BRAIN AND BEHAVIOR, 2013, 3 (04): : 487 - 493
  • [9] Japanese Alzheimer's Disease Neuroimaging Initiative: Present status and future
    Iwatsubo, Takeshi
    [J]. ALZHEIMERS & DEMENTIA, 2010, 6 (03) : 297 - 299
  • [10] Appropriate Use Criteria for Amyloid PET: A Report of the Amyloid Imaging Task Force, the Society of Nuclear Medicine and Molecular Imaging, and the Alzheimer's Association
    Johnson, Keith A.
    Minoshima, Satoshi
    Bohnen, Nicolaas I.
    Donohoe, Kevin J.
    Foster, Norman L.
    Herscovitch, Peter
    Karlawish, Jason H.
    Rowe, Christopher C.
    Carrillo, Maria C.
    Hartley, Dean M.
    Hedrick, Saima
    Pappas, Virginia
    Thies, William H.
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2013, 54 (03) : 476 - 490